Tech Company Financing Transactions
Hornet Therapeutics Funding Round
Hornet Therapeutics closed a Seed financing round on 5/28/2024. Backers included 4BIO Capital.
Transaction Overview
Company Name
Announced On
5/28/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
48 Warwick Street
London, W1B 5AW
UK
London, W1B 5AW
UK
Phone
Undisclosed
Website
Email Address
Overview
Hornet Therapeutics ("Hornet") is a biotech company focused on developing treatments to address Epstein-Barr Virus (EBV) driven pathologies. The Company was founded by 4BIO Capital and Professor Christoph Hess, based on breakthrough work from Christoph Hess's lab on translational aspects of lymphocyte function and its metabolic basis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fraser Gray
Chief Scientific Officer
Christoph Hess
Browse more venture capital transactions:
Prev: 5/28/2024: Braavo Capital venture capital transaction
Next: 5/28/2024: Swiipr Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document all VC transactions involving tech companies. VC transactions reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs